MMP9 and ductal breast carcinoma in situ: We, and others, have shown that MECs are altered in DCIS and we recently demonstrated that upregulation of the integrin αvβ6 by DCIS-associated MEC confers tumour-promoter activity on MECs through TGF-β-mediated upregulation of MMP-9 [27].